HomeInsights52 Week High Stocks

Remus Pharmaceuticals Ltd 52 Week High

Remus Pharmaceuticals Ltd 52 Week High

stocks purchased

₹ 0.3 Cr

Volume Transacted

()

stocks purchased

1.4 K

Stocks Traded

()

Last Updated on: Dec 13, 2024

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

YEARHIGH

₹ 2834.75

Last updated on: Dec 12, 2024

Key Highlights

  • The 52 Week HIGH of Remus Pharmaceuticals Ltd is ₹ 2834 as of 12 Dec 24 .

Company Fundamentals for Remus Pharmaceuticals Ltd

No data available

Market Price of Remus Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20242500
11 Dec 20242511.6
10 Dec 20242556.05
09 Dec 20242587.05
06 Dec 20242571.75
05 Dec 20242566.85
04 Dec 20242624.45
03 Dec 20242640
02 Dec 20242645.05
29 Nov 20242710.5

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Remus Pharmaceuticals Ltd News Hub

News

Board of Remus Pharmaceuticals recommends interim dividend

Remus Pharmaceuticals announced that the Board of Directors of the Company at its meeting ...

Read more

09 Nov 2024 16:57

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 2024 10:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 2024 15:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 2024 12:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 2024 10:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 2024 15:16

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Remus Pharmaceuticals Ltd

What is the significance of Remus Pharmaceuticals Ltd reaching its 52-week high?

Remus Pharmaceuticals Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Remus Pharmaceuticals Ltd 52-week high?

Investors monitor Remus Pharmaceuticals Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Remus Pharmaceuticals Ltd a good buy when it hits its 52-week high?

Whether Remus Pharmaceuticals Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Remus Pharmaceuticals Ltd fundamentals.

What should I consider before investing in Remus Pharmaceuticals Ltd at its 52-week high?

Before investing in Remus Pharmaceuticals Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Remus Pharmaceuticals Ltd stock price continue to rise after reaching its 52-week high?

Remus Pharmaceuticals Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions